Phase 1 Rectal Cancer trials recruiting now
All Rectal Cancer trials, every phase
12
Phase 1 recruiting
Other phases for Rectal Cancer
Phase 1 Rectal Cancer trials
- A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
- A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
- Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
- Brodalumab in the Treatment of Immune-Related Adverse Events
- CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
- CEA-Targeted CAR-T Therapy in CEA-Positive Advanced Solid Tumors
- Clinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes(CAR-T) for CEA Positive Advanced Malignant Solid Tumors
- Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
- Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer
- F-Tryptophan PET/CT in Human Cancers
- PRE-ISPY Phase I/II Oncology Platform Program
- Sintilimab Plus Hypofractionated Radiotherapy for MSI-H/dMMR Rectal Cancer
Common questions
What does Phase 1 mean?
Is this list complete?
No. For the full record, search ClinicalTrials.gov.